Thinzar Wai

Thinzar Wai practices at Kaleida Health - Unit in Buffalo, New York.

Thinzar Wai's NPI, 1124519574, was assigned on May 22, 2018. Thinzar Wai graduated from University of Medicine 2 Yangon in 2010. Thinzar Wai holds New York license 321010.

Thinzar Wai's primary practice is Kaleida Health - Unit, at 100 High St., Buffalo, NY 14203 in Erie County. The practice phone is (716) 859-2556.

Thinzar Wai's primary practice is Kaleida Health - Unit in Buffalo, New York. Thinzar Wai is also affiliated with Strong Memorial Hospital. The medical group on file is University of Rochester Medical Faculty Group (URMFG). Dmand AI also links Thinzar Wai to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Thinzar Wai practices, 2 sites in all. Vendor and product names are available with a free account.

Infectious disease is Thinzar Wai's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Thinzar Wai is licensed in New York.

CMS data shows 78 Medicare services from Thinzar Wai across 2 procedure codes in 2024, for 72 Medicare patients. Medicare paid $6,038 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 72 Medicare patients who saw Thinzar Wai in 2024. The largest group is under 65, with 26 patients. 75% of them have high blood pressure, and 68% have high cholesterol. 54% are also on Medicaid. Their average risk score is 4.12, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Thinzar Wai's median patient age at 62, with 48% women.

In 2024, Thinzar Wai wrote 99 Medicare Part D claims for 24 patients. 93% of them were for generic drugs. CMS names the drug for 43 of them, across 3 drugs with 11 or more claims each, at $2,101 in total drug cost. In 2019, CMS named 48 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Thinzar Wai for performance year 2024, reported as part of a group. Thinzar Wai accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Thinzar Wai from 1 drug or device company in 2024. Food and beverage make up the largest share, 100% of the total. Amgen Inc. paid the most, $115.

Thinzar Wai graduated from University of Medicine 2 Yangon in 2010.